Cargando…
Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study
INTRODUCTION: Cross-talk between the coagulation system and inflammatory reactions during sepsis causes organ damage followed by multiple organ dysfunction syndrome or even death. Therefore, anticoagulant therapies have been expected to be beneficial in the treatment of severe sepsis. Recombinant hu...
Autores principales: | Yamakawa, Kazuma, Fujimi, Satoshi, Mohri, Tomoyoshi, Matsuda, Hiroki, Nakamori, Yasushi, Hirose, Tomoya, Tasaki, Osamu, Ogura, Hiroshi, Kuwagata, Yasuyuki, Hamasaki, Toshimitsu, Shimazu, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218981/ https://www.ncbi.nlm.nih.gov/pubmed/21569368 http://dx.doi.org/10.1186/cc10228 |
Ejemplares similares
-
Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
por: Yamakawa, Kazuma, et al.
Publicado: (2013) -
Assessment of risk factors related to healthcare-associated methicillin-resistant Staphylococcus aureus infection at patient admission to an intensive care unit in Japan
por: Yamakawa, Kazuma, et al.
Publicado: (2011) -
Impact on survival of whole-body computed tomography before emergency bleeding control in patients with severe blunt trauma
por: Wada, Daiki, et al.
Publicado: (2013) -
Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
por: Yoshimura, Jumpei, et al.
Publicado: (2015) -
A novel technique of differential lung ventilation in the critical care setting
por: Yamakawa, Kazuma, et al.
Publicado: (2011)